Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: MAXIM BIOMEDICAL, INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2020-08-28 to 2022-08-27
Current total value of award: $5253450
Description: EO14042: RADX TECH - MAXIM SARS-COV-2 ANTIGEN RAPID TEST